Meitheal Pharmaceuticals Inc recalls Glycopyrrolate Injection, USP 4mg per 20mL, 20 mL Multi-Dose Vials, Rx only, Mfd for Meitheal Pharmaceuticals, Chicago,
Recalled September 22, 2021 · FDA recall D-0801-2021 · Meitheal Pharmaceuticals
Hazard
Failed Impurities/Degradation Specifications · FDA Class III
Units
1,160 ten-pack cartons
Sold at
Nationwide within the USA and India
Description
Failed Impurities/Degradation Specifications
Product
Glycopyrrolate Injection, USP 4mg per 20mL, 20 mL Multi-Dose Vials, Rx only, Mfd for Meitheal Pharmaceuticals, Chicago, IL 60631. NDC 71288-408-21
Manufacturer(s)
Meitheal Pharmaceuticals Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →